Terns Pharmaceuticals, Inc. (TERN) Income from Non-Controlling Interests (2020)
Terns Pharmaceuticals (TERN) has disclosed Income from Non-Controlling Interests for 1 consecutive years, with -$28000.0 as the latest value for Q4 2020.
- For the quarter ending Q4 2020, Income from Non-Controlling Interests changed N/A year-over-year to -$28000.0, compared with a TTM value of -$518000.0 through Dec 2020, changed N/A, and an annual FY2020 reading of -$518000.0, changed N/A over the prior year.
- Income from Non-Controlling Interests was -$28000.0 for Q4 2020 at Terns Pharmaceuticals, up from -$128000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$28000.0 in Q4 2020 and bottomed at -$205000.0 in Q1 2020.